BE710483A - - Google Patents

Info

Publication number
BE710483A
BE710483A BE710483DA BE710483A BE 710483 A BE710483 A BE 710483A BE 710483D A BE710483D A BE 710483DA BE 710483 A BE710483 A BE 710483A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE710483A publication Critical patent/BE710483A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE710483D 1967-11-24 1968-02-07 BE710483A (US20030204162A1-20031030-M00001.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR129489A FR6928M (US20030204162A1-20031030-M00001.png) 1967-11-24 1967-11-24

Publications (1)

Publication Number Publication Date
BE710483A true BE710483A (US20030204162A1-20031030-M00001.png) 1968-06-17

Family

ID=8642199

Family Applications (1)

Application Number Title Priority Date Filing Date
BE710483D BE710483A (US20030204162A1-20031030-M00001.png) 1967-11-24 1968-02-07

Country Status (3)

Country Link
BE (1) BE710483A (US20030204162A1-20031030-M00001.png)
FR (1) FR6928M (US20030204162A1-20031030-M00001.png)
GB (1) GB1175808A (US20030204162A1-20031030-M00001.png)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2048090B1 (es) * 1992-01-31 1994-10-01 Rovi Lab Farmaceut Sa Procedimiento para la obtencion de nuevos antitromboticos derivados de la cumarina.
AU5259296A (en) * 1995-04-07 1996-10-23 Warner-Lambert Company Flavones and coumarins as agents for the treatment of athero sclerosis
US7846915B2 (en) 2004-10-20 2010-12-07 Resverlogix Corporation Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
WO2007016525A2 (en) * 2005-07-29 2007-02-08 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
CA2676984C (en) 2007-02-01 2015-03-17 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular diseases
KR101629356B1 (ko) 2008-06-26 2016-06-13 리스버로직스 코퍼레이션 퀴나졸리논 유도체의 제조방법
JP5635535B2 (ja) 2009-01-08 2014-12-03 レスバーロジックス コーポレイション 心血管疾患の予防および治療のための化合物
NZ595747A (en) 2009-03-18 2015-06-26 Resverlogix Corp Novel quinazolinones and related compounds for use as anti-inflammatory agents
EP3431086B1 (en) 2009-04-22 2020-06-17 Resverlogix Corp. Novel anti-inflammatory agents
JP5992049B2 (ja) 2011-11-01 2016-09-14 レスバーロジックス コーポレイション 置換されたキナゾリノンのための経口速放性製剤
WO2014080290A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Cyclic amines as bromodomain inhibitors
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
WO2014096965A2 (en) 2012-12-21 2014-06-26 Rvx Therapeutics Inc. Novel heterocyclic compounds as bromodomain inhibitors
JO3789B1 (ar) 2015-03-13 2021-01-31 Resverlogix Corp التراكيب والوسائل العلاجية المعتمدة لمعالجة الامراض المتعلقة بالمتممة

Also Published As

Publication number Publication date
FR6928M (US20030204162A1-20031030-M00001.png) 1969-05-05
GB1175808A (en) 1969-12-23

Similar Documents

Publication Publication Date Title
AU5765369A (US20030204162A1-20031030-M00001.png)
AU2116667A (US20030204162A1-20031030-M00001.png)
BE708996A (US20030204162A1-20031030-M00001.png)
BE711013A (US20030204162A1-20031030-M00001.png)
BE710563A (US20030204162A1-20031030-M00001.png)
BE710358A (US20030204162A1-20031030-M00001.png)
BE710334A (US20030204162A1-20031030-M00001.png)
BE710272A (US20030204162A1-20031030-M00001.png)
BE710157A (US20030204162A1-20031030-M00001.png)
BE711467A (US20030204162A1-20031030-M00001.png)
BE709976A (US20030204162A1-20031030-M00001.png)
BE709392A (US20030204162A1-20031030-M00001.png)
BE709052A (US20030204162A1-20031030-M00001.png)
AU1868267A (US20030204162A1-20031030-M00001.png)
BE705788A (US20030204162A1-20031030-M00001.png)
BE699145A (US20030204162A1-20031030-M00001.png)
BE692780A (US20030204162A1-20031030-M00001.png)
BE692779A (US20030204162A1-20031030-M00001.png)
BE692778A (US20030204162A1-20031030-M00001.png)
BE692654A (US20030204162A1-20031030-M00001.png)
BE692577A (US20030204162A1-20031030-M00001.png)
BE692553A (US20030204162A1-20031030-M00001.png)
BE692552A (US20030204162A1-20031030-M00001.png)
BE710483A (US20030204162A1-20031030-M00001.png)
BE692493A (US20030204162A1-20031030-M00001.png)